These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10496046)

  • 1. [Correlation between clinical aggressiveness of thymic epithelial tumors and expression of tumor suppressor gene products (p53, p27)].
    Fukiwake N; Kase S; Yamazaki K; Yano T; Sugimachi K
    Fukuoka Igaku Zasshi; 1999 Aug; 90(8):339-41. PubMed ID: 10496046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cell cycle regulator proteins in encapsulated thymomas.
    Baldi A; Ambrogi V; Mineo D; Mellone P; Campioni M; Citro G; Mineo TC
    Clin Cancer Res; 2005 Jul; 11(14):5078-83. PubMed ID: 16033820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
    Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent intrathoracic thymomas: potential prognostic importance of cell-cycle protein expression.
    Mineo TC; Ambrogi V; Baldi A; Pompeo E; Mineo D
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):40-5. PubMed ID: 19577054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation: common in thymic carcinomas, rare in thymomas.
    Suzuki M; Chen H; Shigematsu H; Ando S; Iida T; Nakajima T; Fujisawa T; Kimura H
    Oncol Rep; 2005 Dec; 14(6):1621-4. PubMed ID: 16273266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor expression in invasive thymoma.
    Henley JD; Koukoulis GK; Loehrer PJ
    J Cancer Res Clin Oncol; 2002 Mar; 128(3):167-70. PubMed ID: 11935304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical study of p53, p27 and PCNA expression in esophageal cancer].
    Sakurai K; Hata S; Amano S; Kimura T; Hori A; Sakamoto A; Kimizuka K; Mimatsu K; Nishio S; Miyake H; Shibata M; Fukuzawa M
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1269-72. PubMed ID: 9703805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma.
    Hirabayashi H; Fujii Y; Sakaguchi M; Tanaka H; Yoon HE; Komoto Y; Inoue M; Miyoshi S; Matsuda H
    Int J Cancer; 1997 Nov; 73(5):639-44. PubMed ID: 9398039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel.
    Arber N; Hibshoosh H; Yasui W; Neugut AI; Hibshoosh A; Yao Y; Sgambato A; Yamamoto H; Shapira I; Rosenman D; Fabian I; Weinstein IB; Tahara E; Holt PR
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1101-5. PubMed ID: 10613343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
    McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
    Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness.
    Chen FF; Yan JJ; Jin YT; Su IJ
    Hum Pathol; 1996 Oct; 27(10):1089-92. PubMed ID: 8892596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of tumour-related genes in thymic epithelial tumours.
    Hirose Y; Kondo K; Takizawa H; Nagao T; Nakagawa Y; Fujino H; Toba H; Kenzaki K; Sakiyama S; Tangoku A
    Lung Cancer; 2009 May; 64(2):155-9. PubMed ID: 18778870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
    Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
    Mod Pathol; 2001 May; 14(5):371-6. PubMed ID: 11353044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of p21Waf1 expression is a strong predictor of reduced survival in primary superficial bladder cancers.
    Migaldi M; Sgambato A; Garagnani L; Ardito R; Ferrari P; De Gaetani C; Cittadini A; Trentini GP
    Clin Cancer Res; 2000 Aug; 6(8):3131-8. PubMed ID: 10955794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
    Hirabayashi H; Ohta M; Tanaka H; Sakaguchi M; Fujii Y; Miyoshi S; Matsuda H
    J Surg Oncol; 2002 Dec; 81(4):177-84; discussion 184. PubMed ID: 12451621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer.
    Ben-Izhak O; Lahav-Baratz S; Meretyk S; Ben-Eliezer S; Sabo E; Dirnfeld M; Cohen S; Ciechanover A
    J Urol; 2003 Jul; 170(1):241-5. PubMed ID: 12796697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of cell cycle regulators p21, p27, and p53 in tumors of salivary glands and paranasal sinuses.
    Affolter A; Helmbrecht S; Finger S; Hörmann K; Götte K
    Oncol Rep; 2005 Jun; 13(6):1089-94. PubMed ID: 15870926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
    Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.